Wegovy for Teens: Questions for a Pediatric Appointment

The short answer

The Wegovy shot is FDA-approved for teenagers 12 and older with obesity¹. In the main teen trial, kids on it saw their BMI fall by about 16% over 68 weeks, while the placebo group's rose slightly². The American Academy of Pediatrics now says doctors should offer medication to teens 12 and up with obesity, weighing each drug's risks and benefits³.

Why I read this one

I would not apply adult treatment expectations to a teenager. I read the label, the adolescent trial and the pediatric guideline to separate age eligibility, expected benefit and follow-up. I would want the young person included in that conversation, rather than make a decision from an adult’s before-and-after.

Which medicines are approved for teens

That is from each drug's own label^1,4,5. This table compares these selected products; it is not an exhaustive list of pediatric obesity medicines. Wegovy’s adolescent maintenance options are 1.7 mg or2.4 mg weekly, with2.4 mg recommended. The adult 7.2 mg option should not be assumed to apply to a teenager.

What the teen trial found

The trial behind the approval, called STEP TEENS, enrolled 201 adolescents aged 12 to 17. They were randomly split two to one between weekly semaglutide and a placebo, for 68 weeks, and everyone also got help with eating and activity².

The trial was funded by the company that makes Wegovy. That doesn't make the result wrong, and the FDA reviewed it, but it is worth knowing.

The side effects, for a kid

In the label's teen data, 42% of teens on the drug had nausea and 36% vomiting, compared with 18% and 10% on placebo¹. The label also says teens had more gallstones, gallbladder inflammation, low blood pressure, rash and hives than adults on the same drug.

I would plan for the possibility of vomiting rather than treat it as a minor inconvenience. A teenager throwing up before school is a different problem from an adult doing it at home. I would want to know how the doctor handles a dose that isn't tolerated, and what a teen should do if they can't keep fluids down.

What the pediatricians' guideline says

The American Academy of Pediatrics published its obesity guideline in 2023. Its statement on medication is short: doctors should offer adolescents 12 and older with obesity weight-loss medication, according to the medicine's indications, risks and benefits³.

The AAP's own summary for parents says plainly that weight is a sensitive subject and that children and teens are especially aware of the unfair stigma attached to it³. That landed with me more than any number on this page.

How I would talk about it at home

I would keep the conversation about health, comfort and function rather than appearance. I would ask the clinician how the adolescent’s concerns and preferences will be included, and how treatment can avoid adding shame. I would want space for questions in private as well as with a caregiver present.

Coverage

Medicaid has to cover medically necessary care for children under its EPSDT benefit, which can include these drugs, even in states that don't cover them for adults⁶. Private plans vary, so the pharmacy and the plan are the people to ask. The online services I review here are built around adults, so this is a conversation for your teen's own pediatrician.

I would also ask what the family can do if nausea interferes with meals or school, and who reviews a concern between visits. I would not interpret a trial average as an individual target or ask a teen to tolerate serious symptoms to reach it.

Questions I would bring

• Is my child's BMI in the range the label is written for?
• What happens to the weight if we stop?
• How will we watch for gallbladder trouble?
• Who do we call on a day they can't keep anything down?

If your teen has severe stomach pain that will not go away, call their doctor right away or go to urgent care.